Document Detail


Prophylactic intravenous immunoglobulin replacement in high-risk burn patients.
MedLine Citation:
PMID:  2822723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty patients with extensive thermal injury were entered into a prospective randomized double-blind trial of prophylactic intravenous immunoglobulin administration. Ten patients received intravenous immunoglobulin and ten, albumin controls. No statistically significant difference was found between mortality rates, mortality rates from sepsis, the incidence of positive blood cultures, the positive quantitative wound biopsies, urine cultures, or positive intravenous line cultures. No significant improvement was noted in assays of neutrophil chemotactic index or intracellular kill, assays of lymphocyte function, or helper/suppressor ratio. We did, however, note significant improvement in the incidence of polymicrobial blood cultures, cytomegalovirus titers, and blood endotoxin concentration in treated patients. While the high incidence of inhalation injury (16 out of 20 patients) and, therefore, the disproportionately high mortality rate (40% overall) in the study group do not permit extension of these observations to the burn patient population at large, certain cautious recommendations may be made with regard to the use of intravenous immunoglobulin G in the management of burn patients.
Authors:
A M Munster; K T Moran; J Thupari; M Allo; R A Winchurch
Related Documents :
20397003 - Neutrophil gelatinase-associated lipocalin in adult septic patients with and without ac...
1558683 - Sensitivity to silver in a patient treated with silver sulphadiazine (flamazine).
10776713 - The utility of selective screening for carotid stenosis in cardiac surgery patients.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of burn care & rehabilitation     Volume:  8     ISSN:  0273-8481     ISO Abbreviation:  J Burn Care Rehabil     Publication Date:    1987 Sep-Oct
Date Detail:
Created Date:  1987-12-02     Completed Date:  1987-12-02     Revised Date:  2006-08-15    
Medline Journal Info:
Nlm Unique ID:  8110188     Medline TA:  J Burn Care Rehabil     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  376-80     Citation Subset:  IM    
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, MD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Albumins / therapeutic use
Burns / microbiology,  mortality,  therapy*
Child
Child, Preschool
Cytomegalovirus / isolation & purification
Double-Blind Method
Endotoxins / blood
Female
Humans
Immunoglobulin G / administration & dosage*,  pharmacokinetics
Infant
Infusions, Intravenous
Lymphocytes / immunology
Male
Middle Aged
Neutrophils / immunology
Prospective Studies
Random Allocation
Chemical
Reg. No./Substance:
0/Albumins; 0/Endotoxins; 0/Immunoglobulin G

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bilateral non-traumatic aseptic osteonecrosis in the femoral head. An experimental study of incidenc...
Next Document:  Characterization of ribosomal RNA synthesis in a gene dosage mutant: the relationship of topoisomera...